Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 16, 2019
Experic has announced Denise Sabaday as vice president of business development.
read more
Exyte and Univercells Technologies are announcing a global partnership for optimized construction of modular standardized and flexible GMP manufacturing facilities for vaccines.
read more
Thursday, August 13, 2020
Eyenovia has entered into a license agreement for Arctic Vision to develop and commercialize MicroPine in Greater China and South Korea.
read more
Wednesday, January 29, 2020
EyePoint and Ocumension announced a license agreement for development and commercialization of DEXYCU 9% for post-operative inflammation following ocular surgery in Mainland China, Hong Kong, Macau and Taiwan.
read more
Thursday, February 03, 2022
Fagron has reached an agreement to acquire Letco Medical. The acquisition price is $34 million.
read more
Monday, September 30, 2019
Fate Therapeutics has opened its cGMP compliant manufacturing facility for the clinical production of its off-the-shelf natural killer cell and chimeric antigen receptor (CAR) T-cell product candidates.
read more
The FDA is announcing the availability of a temporary guidance for industry entitled, “Manufacturing, Supply Chain, and Drug and Biological Product Inspections During COVID-19 Public Health Emergency Questions and Answers.”
read more
Wednesday, October 30, 2019
The FDA issued a revised final guidance in January 2017, Guidance for Industry, Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act, which is in place while the FDA develops the 503B...
read more
Wednesday, September 25, 2019
The FDA has announced a voluntary recall of 14 lots of prescription ranitidine capsules distributed by Sandoz used to decrease the amount of acid created by the stomach.
read more
The FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the COVID-19 pandemic.
read more
The FDA has announced the retirement of the MedWatch to Manufacturer Program.
read more
Patients expect and deserve high-quality drugs – this means consistently safe and effective medicines, free of defects and contamination.
read more
Wednesday, April 13, 2022
Biofrontera Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Biofrontera Pharma’s cGMP laboratory in Leverkusen, Germany, as a contract laboratory for batch control and stability testing of Ameluz® (aminolevulinic acid ...
read more
Tuesday, October 06, 2020
Ajinomoto Bio-Pharma Services announced the FDA has approved the first commercial drug manufactured using the company's AJIPHASE production process.
read more
Thursday, August 16, 2018
Grifols has received approval from the FDA to relocate existing immunodiagnostic manufacturing operations to a new Consolidated Manufacturing Facility in Emeryville, California.
read more